Invivyd, Inc. - Common Stock IVVD 深 沪
等待开盘 09-16 09:30:00 美东时间
1.28
-0.150
-10.49%
华盛通- 最 高1.41
- 今 开1.41
- 成交量 273.72万股
- 最 低 1.25
- 昨 收 1.43
- 总市值 2.50亿
- 52周最高 2.74
- 市盈率 静 --
- 换手率 1.40%
- 52周最低 0.3546
- 委 比 5.55%
- 总股本 1.95亿
- 历史最高 78.82
- 量 比 0.49
- 振 幅 11.19%
- 历史最低 0.3546
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
SPEAR Study Group proposes a clinical study to evaluate monoclonal antibody VYD2311 for treating Long COVID, aiming to reduce circulating spike protein and explore clinical benefits. The study design involves maintaining high antiviral antibody levels to suppress chronic infection. Researchers Amy Proal and David Putrino will present the proposal to RECOVER-TLC. VYD2311 is expected to be a promising candidate for addressing persistent viral reser...
09-04 11:01
Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller
Billionaire hedge fund manager Steven Cohen is diving into small-cap biotech with new stakes in two clinical-stage companies, signaling confidence in their potential for outsized returns.
08-30 00:42
Point72 Hedge-Fund Manager, Steve Cohen, Discloses 8% Passive Stake In Invivyd
-SEC Filing
08-28 04:58
美股牛股 | 回声星通信飙升70%，AT&T拟以230亿美元收购其频谱许可证；先科电子涨超15%
回声星通信飙升70%，AT&T拟以230亿美元收购其频谱许可证；CareCloud涨超15%，完成对Medsphere的收购；Q2净销售额创下纪录，先科电子涨超15%>>
08-27 15:48
Invivyd to Participate in Upcoming Investor Conferences
Invivyd, Inc. announced it will present at the Cantor Global Healthcare Conference 2025 on September 3, 2025, and the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. Both events will be held in New York, NY. Live webcasts will be available on the company's investor website, investors.invivyd.com, and archived for 30 days. The management team will also host investor meetings. Invivyd, a biopharmaceutical company focu...
08-27 11:01
Invivyd rallies amid interest in COVID therapy
Shares of microcap biotech Invivyd (NASDAQ:IVVD) jumped ~94% on Tuesday to reach the highest level in more than five months, a rally not seen since early this year as the company’s experimental COVID-...
08-27 02:41
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Invivyd, Inc. has completed an underwritten public offering of 89.2 million shares of common stock and pre-funded warrants, raising approximately $57.5 million. The offering was led by Cantor Fitzgerald with participation from RA Capital Management and Janus Henderson Investors. Proceeds will be used for clinical program advancements, R&D initiatives, and general corporate purposes. The company, focused on developing antibodies against viral infe...
08-22 16:00
生物制药公司Invivyd将发行证券融资5000万美元
美股周四早盘，生物制药公司Invivyd（IVVD）股价重挫18%，此前该公司宣布通过证券发行筹集5000万美元资金。这笔融资将用于支持临床项目，包括针对长...
08-21 22:15
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
Invivyd, Inc. announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at $0.52 per share and pre-funded warrants for 21,342,442 shares at $0.5199 per warrant. The offering is expected to raise approximately $50 million in gross proceeds. Invivyd has granted underwriters a 30-day option to purchase an additional 14,423,076 shares. The funds will be used for clinical programs, R&D, and general corporate pur...
08-21 03:58
